STERIS plc at Morgan Stanley Global Healthcare Conference Transcript

Sep 13, 2023 / 12:10PM GMT
Patrick Wood -

Okay. Good morning, everyone. Thank you so much for being here. Patrick Wood. I run the U.S. Medtech team. I'm very excited to have Dan Carestio here, CEO of STERIS. Before we start, some disclaimers. There's usually a little a board here, so I'm going to ask about memory, Pretty sure that's the one. I'm sure you're all be going there. Or you can reach out to your Morgan Stanley sales rep either way. It should be good. Dan, thank you so much for joining us. I really appreciate it.

Questions and Answers:

Patrick Wood -

Maybe just to jump right into it, last quarter had some very strong capital equipment trends for you guys. Obviously, you came into it with quite a big backlog, but there's still quite a big backlog. Maybe you could just speak to sort of where you're seeing some of the strength, the type of demand, products, the durability, any comments around that?

Daniel A. Carestio - STERIS plc - President, CEO & Director

I think we've been especially strong in sterile
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
4.6 out of 5 Trustpilot